differ among groups (P ¼ 0.5), but overall survival was lower in the AS group (65.9%, P ¼ 0.01) compared to PN (91.9%), RN (89.6%), and ablation (82.9%). From 193 patients, median GFR at enrollment was similar at 71.3, 68.1, 55.5, and 69.5 mL/min/1.73 m 2 in the PN, RN, ablation, and AS groups, respectively (P ¼ 0.7); at a median follow-up time of 1.5 years, the median GFR was 69.3, 43.7, 55.7, and 68.0 mL/ min/1.73 m 2 across the respective groups (P ¼ 0.2). From a total of 1,932 SF-12 questionnaires, PN patients reported significantly higher PCS scores compared to AS patients at enrollment and annually thereafter until year 5. Patients in AS demonstrated lower PCS scores over time (P ¼ 0.01), but MCS was not meaningfully different among groups or across time.
INTRODUCTION AND OBJECTIVES: Minimally-invasive treatments of clinically localized renal tumors such as robot-assisted partial nephrectomy (RAPN) and percutaneous Thermal Ablations (TA) are routinely performed in our institution. The objectives were to describe our indications and assess the morbidity and the efficacy of each one of the techniques METHODS: From our prospectively maintained database UroCCR (French national Database on Kidney Cancer), we retrospectively reviewed RAPN and TA procedures performed between 2003 and 2016. Pre-operative, intra-operative, postoperative and follow up data were collected. Chi2 and Wilcoxon tests were used for comparisons. Kaplan Meier curves and Log rank test were used to determine survivals and predictive factors of local recurrence.
RESULTS: We reviewed 397 procedures including, 232 RAPN and 165 TA. RAPN patients were younger (61 vs 73 yo, p<0.001), less often solitary kidney (4.9% vs 34.8%, p<0.001) or bilateral tumor (p<0.001) and had a lower ASA score. Post-operative complications occurred in 34 and 18 cases after RAPN and TA respectively (14.6% vs 10.8%, p¼0.08). RAPN patients had more post-operative transfusion (7.7% vs 0.6%, p<0.001) and the Clavien grade of complications was higher (p¼0,016). There was no difference on post-operative glomerular filtration rate (GFR) between the 2 groups (-5.3 vs -5.6 ml/min/1.73m2, p¼0.32). Among the 342 patients with a proven malignant tumor, the rate of local recurrence, metastatic progression and death were lower with RAPN (3%, 2.4%, 1.9%, respectively) than TA (17.5%, 10.3%, 13.8%, p<0.001). In multivariate analysis, the only independent predictive factor of local recurrence was the endophytic character of the tumor OR 3.51 (1.01-12.20), p¼0.04 CONCLUSIONS: RAPN and TA allow offering a safe minimally invasive treatment whatever the patients profile is. Post-operative renal function and complication rates were not significantly different between the 2 groups. However, we experienced more major complications after RAPN and more local recurrence after TA Source of Funding: none MP55-20 ADOPTION OF ROBOTIC PARTIAL NEPHRECTOMY: ITS EFFECT ON RENAL CANCER SURGERY AND KAISER PERMANENTE SOUTHERN CALIFORNIA PRACTICE PATTERNS Ramzi Jabaji*, Los Angeles, CA; Heidi Fischer, Pasadena, CA; Gary Chien, Los Angeles, CA INTRODUCTION AND OBJECTIVES: The rapid adoption of robotic surgery in the US has introduced a paradigm change, with over 80 percent of all prostatectomies for prostate cancer being performed robotically in 2015. For renal cancer, the trend has not been previously reported. We aim to evaluate the trend in surgical management of renal cancer in the last 8 years at Kaiser Permanente Southern California (KPSC).
METHODS: From Jan 2008 to Dec 2015, all patients at KPSC who underwent surgical treatment for renal cancer were included retrospectively. Trends in surgical technique and approach, patients' age, gender, clinicopathology, Charlson Comorbidity Index score, chronic kidney disease status were used to identify factors associated with the surgical technique using robust Poisson multivariate regression models.
RESULTS: During this period 3163 patients were included. Robotic partial nephrectomy (PN) was approved by KPSC in March 2011, and its relative use amongst all renal cancer surgery increased by 125%, 45%, and 14% the following 3 years. Laparoscopic PN and laparoscopic radical nephrectomy (RN) were the most common surgeries, but decreased when robotic PN was introduced, and was surpassed by robotic PN in 2012 and 2014, respectively. In a multivariable model, use of partial nephrectomy was associated with lower pathologic T stage (p < 0.001) and lower Charlson Comorbidity Index score (p ¼ .0037) compared with RN. Within subset analysis of partial nephrectomies performed from 2011-2015, minimally invasive approach was not associated with any of the considered covariates.
CONCLUSIONS: Since adoption in 2011, robotic PN has rapidly become the most common surgical modality to treat localized renal cancer. Further studies are necessary to understand the relationship between patient clinical data and surgical approach.
Source of Funding: none e738
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